Samuraciclib hydrochloride hydrate

SKU: orb1686388

Description

Samuraciclib (CT7001) hydrochloride hydrate is an orally bioavailable, ATP-competitive, and selective CDK7 inhibitor (IC50 = 41 nM). It demonstrates potent anti-proliferative activity in breast cancer cell lines (GI50 0.2-0.3 µM) and has shown efficacy in vivo, supporting its investigation in oncology research, particularly for hormone receptor-positive breast cancer.

Research Area

Cell Biology

Key Properties

• MW: 521.7
• Formula: C₂₂H₃₅ClN₆O₃
• Target: Others,Apoptosis,CDK

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

Others,Apoptosis,CDK